| Literature DB >> 16790721 |
T O Crawford1, R L Skolasky, R Fernandez, K J Rosquist, H M Lederman.
Abstract
Ataxia telangiectasia is a rare, multiorgan neurodegenerative disorder with enhanced vulnerability to cancer and infection. Median survival in two large cohorts of patients with this disease, one prospective and one retrospective, is 25 and 19 years, with a wide range. Life expectancy does not correlate well with severity of neurological impairment.Entities:
Mesh:
Year: 2006 PMID: 16790721 PMCID: PMC2082822 DOI: 10.1136/adc.2006.094268
Source DB: PubMed Journal: Arch Dis Child ISSN: 0003-9888 Impact factor: 3.791